STUDY OBJECTIVE: Exposure to cyanide in fires and industrial exposures and intentional cyanide poisoning by terrorists leading to mass casualties is an ongoing threat. Current treatments for cyanide poisoning must be administered intravenously, and no rapid treatment methods are available for mass casualty cyanide exposures. Cobinamide is a cobalamin (vitamin B(12)) analog with an extraordinarily high affinity for cyanide that is more water-soluble than cobalamin. We investigate the use of intramuscular cobinamide sulfite to reverse cyanide toxicity-induced physiologic changes in a sublethal cyanide exposure animal model and determine the ability of an intramuscular cobinamide sulfite injection to rapidly reverse the physiologic effects of cyanide toxicity. METHODS: New Zealand white rabbits were given 10 mg sodium cyanide intravenously over 60 minutes. Quantitative diffuse optical spectroscopy and continuous-wave near-infrared spectroscopy monitoring of tissue oxyhemoglobin and deoxyhemoglobin concentrations were performed concurrently with blood cyanide level measurements and cobinamide levels. Immediately after completion of the cyanide infusion, the rabbits were injected intramuscularly with cobinamide sulfite (n=6) or inactive vehicle (controls, n=5). RESULTS: Intramuscular administration led to rapid mobilization of cobinamide and was extremely effective at reversing the physiologic effects of cyanide on oxyhemoglobin and within deoxyhemoglobin extraction. Recovery time to 63% of their baseline values in the central nervous system occurred within a mean of 1,032 minutes in the control group and 9 minutes in the cobinamide group, with a difference of 1,023 minutes (95% confidence interval 116 to 1,874 minutes). In muscle tissue, recovery times were 76 and 24 minutes, with a difference of 52 minutes (95% confidence interval 7 to 98 minutes). RBC cyanide levels returned toward normal significantly faster in cobinamide sulfite-treated animals than in control animals. CONCLUSION: Intramuscular cobinamide sulfite rapidly and effectively reverses the physiologic effects of cyanide poisoning, suggesting that a compact cyanide antidote kit can be developed for mass casualty cyanide exposures. Copyright (c) 2009 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.
STUDY OBJECTIVE: Exposure to cyanide in fires and industrial exposures and intentional cyanidepoisoning by terrorists leading to mass casualties is an ongoing threat. Current treatments for cyanidepoisoning must be administered intravenously, and no rapid treatment methods are available for mass casualty cyanide exposures. Cobinamide is a cobalamin (vitamin B(12)) analog with an extraordinarily high affinity for cyanide that is more water-soluble than cobalamin. We investigate the use of intramuscular cobinamide sulfite to reverse cyanidetoxicity-induced physiologic changes in a sublethal cyanide exposure animal model and determine the ability of an intramuscular cobinamide sulfite injection to rapidly reverse the physiologic effects of cyanidetoxicity. METHODS: New Zealand white rabbits were given 10 mg sodium cyanide intravenously over 60 minutes. Quantitative diffuse optical spectroscopy and continuous-wave near-infrared spectroscopy monitoring of tissue oxyhemoglobin and deoxyhemoglobin concentrations were performed concurrently with blood cyanide level measurements and cobinamide levels. Immediately after completion of the cyanide infusion, the rabbits were injected intramuscularly with cobinamide sulfite (n=6) or inactive vehicle (controls, n=5). RESULTS: Intramuscular administration led to rapid mobilization of cobinamide and was extremely effective at reversing the physiologic effects of cyanide on oxyhemoglobin and within deoxyhemoglobin extraction. Recovery time to 63% of their baseline values in the central nervous system occurred within a mean of 1,032 minutes in the control group and 9 minutes in the cobinamide group, with a difference of 1,023 minutes (95% confidence interval 116 to 1,874 minutes). In muscle tissue, recovery times were 76 and 24 minutes, with a difference of 52 minutes (95% confidence interval 7 to 98 minutes). RBC cyanide levels returned toward normal significantly faster in cobinamide sulfite-treated animals than in control animals. CONCLUSION: Intramuscular cobinamide sulfite rapidly and effectively reverses the physiologic effects of cyanidepoisoning, suggesting that a compact cyanide antidote kit can be developed for mass casualty cyanide exposures. Copyright (c) 2009 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.
Authors: Kate E Broderick; Prasanth Potluri; Shunhui Zhuang; Immo E Scheffler; Vijay S Sharma; Renate B Pilz; Gerry R Boss Journal: Exp Biol Med (Maywood) Date: 2006-05
Authors: S Merritt; G Gulsen; G Chiou; Y Chu; C Deng; A E Cerussi; A J Durkin; B J Tromberg; O Nalcioglu Journal: Technol Cancer Res Treat Date: 2003-12
Authors: Jangwoen Lee; D J Saltzman; A E Cerussi; D V Gelfand; J Milliken; T Waddington; B J Tromberg; M Brenner Journal: Physiol Meas Date: 2006-06-13 Impact factor: 2.833
Authors: Kate E Broderick; Veena Singh; Shunhui Zhuang; Amanpreet Kambo; Jeffrey C Chen; Vijay S Sharma; Renate B Pilz; Gerry R Boss Journal: J Biol Chem Date: 2005-01-04 Impact factor: 5.157
Authors: Jangwoen Lee; Sari B Mahon; David Mukai; Tanya Burney; Behdod S Katebian; Adriano Chan; Vikhyat S Bebarta; David Yoon; Gerry R Boss; Matthew Brenner Journal: J Med Toxicol Date: 2016-09-15
Authors: Vikhyat S Bebarta; Matthew Brittain; Adriano Chan; Norma Garrett; David Yoon; Tanya Burney; David Mukai; Michael Babin; Renate B Pilz; Sari B Mahon; Matthew Brenner; Gerry R Boss Journal: Ann Emerg Med Date: 2016-12-29 Impact factor: 5.721
Authors: Adriano Chan; Daune L Crankshaw; Alexandre Monteil; Steven E Patterson; Herbert T Nagasawa; Jackie E Briggs; Joseph A Kozocas; Sari B Mahon; Matthew Brenner; Renate B Pilz; Timothy D Bigby; Gerry R Boss Journal: Clin Toxicol (Phila) Date: 2011-06 Impact factor: 4.467
Authors: Jae G Kim; Jangwoen Lee; Sari B Mahon; David Mukai; Steven E Patterson; Gerry R Boss; Bruce J Tromberg; Matthew Brenner Journal: J Biomed Opt Date: 2012-10 Impact factor: 3.170
Authors: Jangwoen Lee; Gary Rockwood; Brian Logue; Erica Manandhar; Ilona Petrikovics; Changhoon Han; Vik Bebarta; Sari B Mahon; Tanya Burney; Matthew Brenner Journal: J Med Toxicol Date: 2018-08-09
Authors: Denis S Salnikov; Sergei V Makarov; Rudi van Eldik; Polina N Kucherenko; Gerry R Boss Journal: Eur J Inorg Chem Date: 2014-09 Impact factor: 2.524
Authors: William C Blackledge; Charles W Blackledge; Alexa Griesel; Sari B Mahon; Matthew Brenner; Renate B Pilz; Gerry R Boss Journal: Anal Chem Date: 2010-05-15 Impact factor: 6.986
Authors: Vikhyat S Bebarta; David A Tanen; Susan Boudreau; Maria Castaneda; Lee A Zarzabal; Toni Vargas; Gerry R Boss Journal: Ann Emerg Med Date: 2014-04-18 Impact factor: 5.721